Greece's rejection of a bailout package weighed the markets down to a lower close with the Dow losing 46 points to 17,683. Nasdaq fell 17 points to 4,991.
On the upside
The Food and Drug Administration removed a partial clinical hold on Versartis' (Nasdaq: VSAR) new drug application for VRS-317.
Shares of ConforMIS (Nasdaq: CFMS) continued rising.
Aetna approved the use of PDI (Nasdaq: PDII) subsidiary Interpace Diagnostics' ThyGenX for assessing fine needle aspiration samples.
On the downside
SouFun Holdings (NYSE: SFUN) shareholders adopted its 2015 Stock Incentive Plan.
Allot Communications (Nasdaq: ALLT) warned that second quarter revenue would fall short of expectations.
HSBC analyst Andy Hargreaves affirmed his Buy rating on Weibo (Nasdaq: WB).
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by 7 to 5 on Nasdaq. The broader S&P 500 fell 8 points to 2068. Bitcoin added $2 to $270.
Lower close after Greece rejects bailout
July 06, 2015 at 17:29 PM EDT